Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1986 Jun;58(3):988–990. doi: 10.1128/jvi.58.3.988-990.1986

Induction of Epstein-Barr virus nuclear antigens.

D J Moss, T B Sculley, J H Pope
PMCID: PMC253013  PMID: 3084809

Abstract

Lymphocytes were infected with the QIMR-WIL strain of Epstein-Barr virus, and the induction of Epstein-Barr virus-associated nuclear antigens was determined by using the protein immunoblot. There was a temporal increase in six antigens, with Epstein-Barr nuclear antigen 2 being detected 1 day after infection. The appearance of these antigens was shown to be independent of cellular DNA synthesis.

Full text

PDF
988

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aya T., Osato T. Early events in transformation of human cord leukobytes by Epstain-Barr virus: induction of DNA synthesis, mitosis and the virus-associated nuclear antigen synthesis. Int J Cancer. 1974 Sep 15;14(3):341–347. doi: 10.1002/ijc.2910140307. [DOI] [PubMed] [Google Scholar]
  2. Boynton A. L., Whitfield J. F., Isaacs R. J., Tremblay R. The control of human WI-38 cell proliferation by extracellular calcium and its elimination by SV-40 virus-induced proliferative transformation. J Cell Physiol. 1977 Aug;92(2):241–247. doi: 10.1002/jcp.1040920212. [DOI] [PubMed] [Google Scholar]
  3. Dambaugh T., Hennessy K., Chamnankit L., Kieff E. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci U S A. 1984 Dec;81(23):7632–7636. doi: 10.1073/pnas.81.23.7632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dillner J., Kallin B., Ehlin-Henriksson B., Timar L., Klein G. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA. Int J Cancer. 1985 Mar 15;35(3):359–366. doi: 10.1002/ijc.2910350312. [DOI] [PubMed] [Google Scholar]
  5. Einhorn L., Ernberg I. Induction of EBNA precedes the first cellular S-phase after EBV-infection of human lymphocytes. Int J Cancer. 1978 Feb 15;21(2):157–160. doi: 10.1002/ijc.2910210205. [DOI] [PubMed] [Google Scholar]
  6. Fischer D. K., Robert M. F., Shedd D., Summers W. P., Robinson J. E., Wolak J., Stefano J. E., Miller G. Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome. Proc Natl Acad Sci U S A. 1984 Jan;81(1):43–47. doi: 10.1073/pnas.81.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Henle W., Diehl V., Kohn G., Zur Hausen H., Henle G. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science. 1967 Sep 1;157(3792):1064–1065. doi: 10.1126/science.157.3792.1064. [DOI] [PubMed] [Google Scholar]
  8. Hennessy K., Kieff E. One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5665–5669. doi: 10.1073/pnas.80.18.5665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  10. Lydon M. J., Keeler K. D., Thomas D. B. Vital DNA staining and cell sorting by flow microfluorometry. J Cell Physiol. 1980 Feb;102(2):175–181. doi: 10.1002/jcp.1041020208. [DOI] [PubMed] [Google Scholar]
  11. Menezes J., Jondal M., Leibold W., Dorval G. Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation. Infect Immun. 1976 Feb;13(2):303–310. doi: 10.1128/iai.13.2.303-310.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Moss D. J., Burrows S. R., Parsons P. G. Calcium concentration defines two stages in transformation of lymphocytes by Epstein-Barr virus. Int J Cancer. 1984 May 15;33(5):587–590. doi: 10.1002/ijc.2910330507. [DOI] [PubMed] [Google Scholar]
  13. Moss D. J., Pope J. H. Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro. J Gen Virol. 1972 Nov;17(2):233–236. doi: 10.1099/0022-1317-17-2-233. [DOI] [PubMed] [Google Scholar]
  14. Moss D. J., Rickinson A. B., Pope J. H. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer. 1978 Dec;22(6):662–668. doi: 10.1002/ijc.2910220604. [DOI] [PubMed] [Google Scholar]
  15. Pope J. H. Establishment of cell lines from Australian leukaemic patients: presence of a herpes-like virus. Aust J Exp Biol Med Sci. 1968 Oct;46(5):643–645. doi: 10.1038/icb.1968.171. [DOI] [PubMed] [Google Scholar]
  16. Pope J. H., Horne M. K., Scott W. Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus. Int J Cancer. 1968 Nov 15;3(6):857–866. doi: 10.1002/ijc.2910030619. [DOI] [PubMed] [Google Scholar]
  17. Reedman B. M., Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer. 1973 May;11(3):499–520. doi: 10.1002/ijc.2910110302. [DOI] [PubMed] [Google Scholar]
  18. Sculley T. B., Sculley D. G., Pope J. H. Identification of Epstein-Barr virus-induced polypeptides in P3HR-1 cells by protein immunoblot. J Gen Virol. 1985 May;66(Pt 5):1113–1122. doi: 10.1099/0022-1317-66-5-1113. [DOI] [PubMed] [Google Scholar]
  19. Sculley T. B., Walker P. J., Moss D. J., Pope J. H. Identification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis. J Virol. 1984 Oct;52(1):88–93. doi: 10.1128/jvi.52.1.88-93.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Spelsberg T. C., Sculley T. B., Pikler G. M., Gilbert J. A., Pearson G. R. Evidence for two classes of chromatin-associated Epstein-Barr virus-determined nuclear antigen. J Virol. 1982 Aug;43(2):555–565. doi: 10.1128/jvi.43.2.555-565.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Strnad B. C., Schuster T. C., Hopkins R. F., 3rd, Neubauer R. H., Rabin H. Identification of an Epstein-Barr virus nuclear antigen by fluoroimmunoelectrophoresis and radioimmunoelectrophoresis. J Virol. 1981 Jun;38(3):996–1004. doi: 10.1128/jvi.38.3.996-1004.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Whitfield J. F., Rixon R. H., MacManus J. P., Balk S. D. Calcium, cyclic adenosine 3',5'-monophosphate, and the control of cell proliferation: a review. In Vitro. 1973 Jan-Feb;8(4):257–278. doi: 10.1007/BF02615905. [DOI] [PubMed] [Google Scholar]
  23. Zerbini M., Ernberg I. Can Epstein-Barr virus infect and transform all the B-lymphocytes of human cord blood? J Gen Virol. 1983 Mar;64(Pt 3):539–547. doi: 10.1099/0022-1317-64-3-539. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES